Market Wire - Pharmaceuticals and Biotech: Drugs (Free subscription) | 25/09/2008
SHANGHAI, CHINA (MARKET WIRE)
EuroInvestor.co.uk (Free subscription) | 18/09/2008
VENLO, The Netherlands, Sept. 18, 2008 (GLOBE NEWSWIRE) -- QIAGEN N.V. (Nasdaq:QGEN) (Frankfurt:QIA) today announced that it will present at the 2008 UBS Global Life Sciences Conference at 12:00 p.m.. - Read more
Market Wire - Pharmaceuticals and Biotech (Free subscription) | 19/08/2008
VENLO, THE NETHERLANDS (MARKET WIRE)
Business Wire (Free subscription) | 08/08/2008
CHICAGO--(BUSINESS WIRE)--Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting
Market Wire (Free subscription) | 04/08/2008
VENLO, THE NETHERLANDS (MARKET WIRE) New cervical cancer prevention guidelines issued by the German Association for Gynecology and Obstetrics (DGGG) recommend testing women 30 and over for HPV (human papillomavirus) -- the primary cause of cervical cancer. The guidelines recommend that HPV testing be performed along with a Pap smear for women 30 and older. The digene® HPV Test, developed by QIAGEN...
PR News Wire (Free subscription) | 29/07/2008
VENLO, The Netherlands, July 29 /PRNewswire-FirstCall/ -- QIAGEN N.V. (Nasdaq: ) today announced the Webcast of its second quarter 2008 financial results call. The Webcast will take place at 9:30 a.m. EDT on Tuesday, August 5, and will include remarks by Peer M. Schatz, President and Chief Executive Officer, and Roland Sackers, Chief Financial Officer. What: Webcast of QIAGEN's second quarter 2008...
Market Watch (Free subscription) | 01/07/2008
TEL AVIV (MarketWatch) -- Qiagen NV, the Venlo, Netherlands, provider of biological sampling and assay technologies, said on Tuesday that it acquired closely held Corbett Life Science Pty. of Sydney. For Corbett, which develops and produces life-sciences instrumentation, Qiagen said it would pay US$66 million cash, $4 million in restricted common stock and as much as US$65 million conditioned on meeting...
Market Wire (Free subscription) | 25/06/2008
KJ VENLO, GERMANY (MARKET WIRE)
Market Wire - Pharmaceuticals and Biotech (Free subscription) | 18/06/2008
VENLO, THE NETHERLANDS (MARKET WIRE)
Market Wire (Free subscription) | 26/05/2008
HILDEN, GERMANY (MARKET WIRE)
Market Wire (Free subscription) | 14/05/2008
VENLO, NETHERLANDS (MARKET WIRE)
Business Wire (Free subscription) | 08/05/2008
CHICAGO--(BUSINESS WIRE)--Zacks Equity Research highlights Onyx Pharmaceuticals (Nasdaq: ONXX) as the Bull of the Day and
Baltimore Sun (Free subscription) | 06/05/2008
Qiagen NV, the Dutch maker of tools for medical research, said first-quarter profit rose 2 percent after it accelerated the integration of Gaithersburg's Digene Corp., a maker of genetic tests purchased last year. Net income increased to $20.3 million from $19.9 million a year earlier, Qiagen said yesterday. Sales rose 62 percent to $207.1 million.
PR News Wire (Free subscription) | 29/04/2008
VENLO, Netherlands, April 29 /PRNewswire-FirstCall/ -- QIAGEN N.V. (Nasdaq: ) announces the following Webcast: What: QIAGEN N.V. - First Quarter 2008 Earnings Announcement When: Tuesday, May 6, 2008 at 9:30am EDT Where: How: Live over the Internet -- Simply log on to the web at the address above. Contact: David Schull of Russo Partners, +1-212-845-4271. If you are unable to participate...
Market Wire - Pharmaceuticals and Biotech: Drugs (Free subscription) | 27/03/2008
MOSBACH, GERMANY (MARKET WIRE)
